Related content

Copper-67 as a therapeutic nuclide for radioimmunotherapy

By Novak-Hofer Ilse   Schubiger August  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 6, 2002-06 ,pp. : 821-830

Springer Publishing Company

Access to resources Recommend Favorite

Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy

By Jain Maneesh   Venkatraman Ganesh   Batra Surinder  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 973-977

Springer Publishing Company

Access to resources Recommend Favorite

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter

By Petrich T.   Helmeke H.-J.   Meyer G.   Knapp W.   Pötter E.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 7, 2002-07 ,pp. : 842-854

Springer Publishing Company

Access to resources Recommend Favorite

High-quality ¹²⁴I-labelled monoclonal antibodies for use as PET scouting agents prior to ¹³¹I-radioimmunotherapy

By Verel Iris   Visser Gerard   Vosjan Maria   Finn Ronald   Boellaard Ronald   Dongen Guus  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1645-1652

Springer Publishing Company

Access to resources Recommend Favorite

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with ⁹⁰Y-radiolabelled ibritumomab tiuxetan (Zevalin)

By Tennvall Jan   Fischer Manfred   Bischof Delaloye Angelika   Bombardieri Emilio   Bodei Lisa   Giammarile Francesco   Lassmann Michael   Oyen Wim   Brans Boudewijn  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 616-622

Springer Publishing Company

Access to resources Recommend Favorite